A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus

Hamed Ekhtiari, Mehran Zare-Bidoky, Arshiya Sangchooli, Amy C Janes, Marc J Kaufman, Jason A Oliver, James J Prisciandaro, Torsten Wüstenberg, Raymond F Anton, Patrick Bach, Alex Baldacchino, Anne Beck, James M Bjork, Judson Brewer, Anna Rose Childress, Eric D Claus, Kelly E Courtney, Mohsen Ebrahimi, Francesca M Filbey, Dara G Ghahremani, Peyman Ghobadi Azbari, Rita Z Goldstein, Anna E Goudriaan, Erica N Grodin, J Paul Hamilton, Colleen A Hanlon, Peyman Hassani-Abharian, Andreas Heinz, Jane E Joseph, Falk Kiefer, Arash Khojasteh Zonoozi, Hedy Kober, Rayus Kuplicki, Qiang Li, Edythe D London, Joseph McClernon, Hamid R Noori, Max M Owens, Martin P Paulus, Irene Perini, Marc Potenza, Stéphane Potvin, Lara Ray, Joseph P Schacht, Dongju Seo, Rajita Sinha, Michael N Smolka, Rainer Spanagel, Vaughn R Steele, Elliot A Stein, Sabine Steins-Loeber, Susan F Tapert, Antonio Verdejo-Garcia, Sabine Vollstädt-Klein, Reagan R Wetherill, Stephen J Wilson, Katie Witkiewitz, Kai Yuan, Xiaochu Zhang, Anna Zilverstand, Hamed Ekhtiari, Mehran Zare-Bidoky, Arshiya Sangchooli, Amy C Janes, Marc J Kaufman, Jason A Oliver, James J Prisciandaro, Torsten Wüstenberg, Raymond F Anton, Patrick Bach, Alex Baldacchino, Anne Beck, James M Bjork, Judson Brewer, Anna Rose Childress, Eric D Claus, Kelly E Courtney, Mohsen Ebrahimi, Francesca M Filbey, Dara G Ghahremani, Peyman Ghobadi Azbari, Rita Z Goldstein, Anna E Goudriaan, Erica N Grodin, J Paul Hamilton, Colleen A Hanlon, Peyman Hassani-Abharian, Andreas Heinz, Jane E Joseph, Falk Kiefer, Arash Khojasteh Zonoozi, Hedy Kober, Rayus Kuplicki, Qiang Li, Edythe D London, Joseph McClernon, Hamid R Noori, Max M Owens, Martin P Paulus, Irene Perini, Marc Potenza, Stéphane Potvin, Lara Ray, Joseph P Schacht, Dongju Seo, Rajita Sinha, Michael N Smolka, Rainer Spanagel, Vaughn R Steele, Elliot A Stein, Sabine Steins-Loeber, Susan F Tapert, Antonio Verdejo-Garcia, Sabine Vollstädt-Klein, Reagan R Wetherill, Stephen J Wilson, Katie Witkiewitz, Kai Yuan, Xiaochu Zhang, Anna Zilverstand

Abstract

Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants' characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: 'Participants' Characteristics', 'General fMRI Information', 'General Task Information', 'Cue Information', 'Craving Assessment Inside Scanner', 'Craving Assessment Outside Scanner' and 'Pre- and Post-Scanning Considerations'. The review of the 108 FDCR papers revealed significant gaps in the reporting of the items considered important by the experts. For instance, whereas items in the 'General fMRI Information' category were reported in 90.5% of the reviewed papers, items in the 'Pre- and Post-Scanning Considerations' category were reported by only 44.7% of reviewed FDCR studies. Considering the notable and sometimes unexpected gaps in the reporting of items deemed to be important by experts in any FDCR study, the protocols could benefit from the adoption of reporting standards. This checklist, a living document to be updated as the field and its methods advance, can help improve experimental design, reporting and the widespread understanding of the FDCR protocols. This checklist can also provide a sample for developing consensus statements for protocols in other areas of task-based fMRI.

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Figures

Extended Data Fig. 1 |. Inter-rater reliability…
Extended Data Fig. 1 |. Inter-rater reliability for individual checklist items.
Inter-rater reliability assessed by Fleiss’ Kappa for each ENIGMA ACRI checklist item, calculated on the basis of the assessment of reporting status of the checklist items among 108 papers by three independent raters.
Extended Data Fig. 2 |. Relationships between…
Extended Data Fig. 2 |. Relationships between reporting score and publication context.
a, Relation between the reporting score of each article and its word count. (Note that article word count is not exactly accurate, because it is measured by counting the words from the beginning of the introduction to the end of the discussion; thus, it might include the running title of each page, footnotes and the captions of figures and tables.) b, Relation between the reporting score of each article and its journal word limit. (Note that the word limitation for journals with no word limitation is counted as 15,000.) c, Relation between the reporting score of each article with journal impact factor. d, Article reporting scores across the years. The relations in panels a, b and c were assessed using linear regressions, whereas a Kruskal-Wallis test was performed for panel d.
Fig. 1 |. Schematic representation of key…
Fig. 1 |. Schematic representation of key reportable aspects of an fMRI drug cue reactivity study.
1. Participants are recruited on the basis of explicit criteria, and baseline data are collected on participant demographics, handedness, psychiatric history and substance use history. 2. Participants undergo fMRI scanning with carefully selected hardware and software parameters, and data are analyzed through specified preprocessing and analysis pipelines for statistical inference. 3. Participants engage with drug and neutral cues during fMRI scanning, with cues of specified durations presented in events and/or blocks with a chosen temporal architecture. 4. These cues stimulate one or more sensory modalities and are typically matched in terms of psychological characteristics, such as induced arousal or valence, and/or physical characteristics, such as saturation and hue for pictorial cues. 5. and 6. Participants provide craving self-reports outside and/or inside the scanner, using various short and long-form instruments and hardware such as response boxes or joysticks. 7. In addition to pre-scanning sources of between-study variance such as task instructions and scanner familiarization, there are important post-scanning safety procedures such as craving-management interventions and additional assessments before participants leave the imaging center.
Fig. 2 |. A schematic of the…
Fig. 2 |. A schematic of the entire Delphi study methodology.
The process has been roughly divided into distinct stages: the selection of the SC (in black) using the results of an earlier mentioned systematic review to choose the initial checklist items and expert committee candidates (in pink), checklist development phase (in red), expert panel selection (in purple), checklist commenting and revision phase (in green), checklist rating phase (in yellow) and data analysis and Delphi process finalization (in blue). The number of contributors to each section is displayed by ‘n =‘. To the left of the main graph, an overview of the structure of the checklist at each stage is presented. recom, recommendations.
Fig. 3 |. Ratings for 38 items…
Fig. 3 |. Ratings for 38 items in seven categories.
This figure depicts the rating of 49 raters (11 from the steering committee and 38 from the expert panel) for the checklist items. Each item was rated from 1 to 5 (not important to extremely important). All the items met threshold 1 and were rated as moderately, highly or extremely important by >70% of the raters. In addition, 24 items reached the more-stringent threshold 2 of being rated as either highly or extremely important by 80% of raters (the ones that did not reach this threshold are marked with ‘†’). Items are represented by their summary in the figure. Full text of the items is provided in Tables 1–6.
Fig. 4 |. Ratings for 75 additional…
Fig. 4 |. Ratings for 75 additional recommendations in seven categories.
This figure depicts the rating of 49 raters (11 from the steering committee and 38 from the expert panel) for the checklist additional recommendations. Each additional recommendation was rated either ‘Yes’ or ‘No’ on the question of whether it should be included as a recommendation. Recommendations are represented by their summary in the figure. Full text of the recommendations is provided in Tables 1–6.
Fig. 5 |. State of reproducibility/transparency in…
Fig. 5 |. State of reproducibility/transparency in fMRI drug cue reactivity research in the context of the ENIGMA-ACRI checklist.
Assessments by three independent raters on the basis of 108 FDCR articles. a, Percentage of articles that reported each checklist item. Note that the percentages are calculated out of applicable items for each article. For example, craving-rating technology was not applicable for an article without craving rating. b, Percentage of overall reporting status of articles.

References

    1. Degenhardt L. et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 5, 987–1012 (2018).
    1. Ekhtiari H. et al. Functional neuroimaging for addiction medicine: from mechanisms to practical considerations. Prog. Brain Res 224, 129–153 (2016).
    1. Moeller SJ & Paulus MP Toward biomarkers of the addicted human brain: using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 80, 143–154 (2018).
    1. Ekhtiari H. et al. Neuroscience of drug craving for addiction medicine: from circuits to therapies. Prog. Brain Res 223, 115–141 (2016).
    1. Ekhtiari H. & ACRI Secretariat. A systematic review on fMRI drug cue reactivity studies (OSF, 2020). (2020).
    1. Bough KJ et al. Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology 39, 202–219 (2014).
    1. Carmichael O. et al. The role of fMRI in drug development. Drug Discov. Today 23, 333–348 (2018).
    1. Zilverstand A. et al. Neuroimaging impaired response inhibition and salience attribution in human drug addiction: a systematic review. Neuron 98, 886–903 (2018).
    1. Cremers HR, Wager TD & Yarkoni T. The relation between statistical power and inference in fMRI. PloS One 12, e0184923 (2017).
    1. Turner BO et al. Small sample sizes reduce the replicability of task-based fMRI studies. Commun. Biol 1, 62 (2018).
    1. Liu TT Noise contributions to the fMRI signal: An overview. Neuroimage 143, 141–151 (2016).
    1. Elliott ML et al. What Is the test-retest reliability of common task-functional MRI measures? New empirical evidence and a meta-analysis. Psychol. Sci 31, 792–806 (2020).
    1. Korucuoglu O. et al. Test-retest reliability of fMRI-measured brain activity during decision making under risk. NeuroImage 214, 116759 (2020).
    1. Kragel P. et al. Functional MRI can be highly reliable, but it depends on what you measure: a commentary on Elliott et al. (2020). Psychol. Sci. 32, 622–626 (2021).
    1. Casey B. et al. The Adolescent Brain Cognitive Development (ABCD) study: imaging acquisition across 21 sites. Dev. Cogn. Neurosci. 32, 43–54 (2018).
    1. Jasinska AJ et al. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci. Biobehav. Rev 38, 1–16 (2014).
    1. Billieux J. et al. The Geneva Appetitive Alcohol Pictures (GAAP): development and preliminary validation. Eur. Addict. Res. 17, 225–230 (2011).
    1. Holla B. et al. Visual image-induced craving for ethanol (VICE): development, validation, and a pilot fMRI study. Indian J. Psychol. Med. 36, 164–169 (2014).
    1. Ekhtiari H. et al. Methamphetamine and Opioid Cue Database (MOCD): development and validation. Drug Alcohol Depend. 209, 107941 (2020).
    1. Khazaal Y, Zullino D. & Billieux J. The Geneva Smoking Pictures: development and preliminary validation. Eur. Addict. Res 18, 103–109 (2012).
    1. Lang PJ, Bradley MM & Cuthbert BN International Affective Picture System (IAPS): Affective Ratings of Pictures and Instruction Manual. (NIMH, Center for the Study of Emotion & Attention, 2005).
    1. Lindquist M. Neuroimaging results altered by varying analysis pipelines. Nature 582, 36–37 (2020).
    1. Nichols TE et al. Best practices in data analysis and sharing in neuroimaging using MRI. Nat. Neurosci 20, 299–303 (2017).
    1. Esteban O. et al. Analysis of task-based functional MRI data preprocessed with fMRIPrep. Nat. Protoc 15, 2186–2202 (2020).
    1. Bossuyt PM et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527 (2015).
    1. Collins GS et al. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement. Circulation 131, 211–219 (2015).
    1. Gagnier JJ et al. The CARE guidelines: consensus-based clinical case reporting guideline development. J. Med. Case Rep 7, 223 (2013).
    1. Moher D. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097 (2009).
    1. Bossuyt PM et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin. Chem 61, 1446–1452 (2015).
    1. Collins GS, Reitsma JB, Altman DG & Moons KG Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Br. J. Surg 102, 148–158 (2015).
    1. Moher D. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg 8, 336–341 (2010).
    1. O’Brien BC et al. Standards for reporting qualitative research: a synthesis of recommendations. Acad. Med. 89, 1245–1251 (2014).
    1. Schulz KF, Altman DG & Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 11, 32 (2010).
    1. Tong A, Sainsbury P. & Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 19, 349–357 (2007).
    1. Von Elm E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull. World Health Organ 85, 867–872 (2007).
    1. Hsu C-C & Sandford BA The Delphi technique: making sense of consensus. Pract. Assess. Res. Eval 12, 10 (2007).
    1. Jorm AF Using the Delphi expert consensus method in mental health research. Aust. N. Z. J. Psychiatry 49, 887–897 (2015).
    1. Yucel M. et al. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study. Addiction 114, 1095–1109 (2019).
    1. Diamond IR et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J. Clin. Epidemiol 67, 401–409 (2014).
    1. Forsman AK et al. Research priorities for public mental health in Europe: recommendations of the ROAMER project. Eur. J. Public Health 25, 249–254 (2015).
    1. Chipchase L. et al. A checklist for assessing the methodological quality of studies using transcranial magnetic stimulation to study the motor system: an international consensus study. Clin. Neurophysiol 123, 1698–1704 (2012).
    1. Hasson F, Keeney S. & McKenna H. Research guidelines for the Delphi survey technique. J. Adv. Nurs 32, 1008–1015 (2000).
    1. Ekhtiari H. Methodological Checklist for fMRI Drug Cue Reactivity Studies: Development and Consensus. Accessed 27 Jan 2020. (2020).
    1. Karoly HC et al. Investigating a novel fMRI cannabis cue reactivity task in youth. Addict. Behav 89, 20–28 (2019).
    1. Rubinstein ML et al. Smoking-related cue-induced brain activation in adolescent light smokers. J. Adolesc. Health 48, 7–12 (2011).
    1. Claus ED et al. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38, 2363–2372 (2013).
    1. Filbey FM et al. Marijuana craving in the brain. Proc. Natl. Acad. Sci. U. S. A. 106, 13016–13021 (2009).
    1. Casey BJ, Jones RM & Hare TA The adolescent brain. Ann. N. Y. Acad. Sci 1124, 111–126 (2008).
    1. Prisciandaro JJ et al. The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction 109, 2062–2070 (2014).
    1. Cheng GLF et al. Heroin abuse accelerates biological aging: a novel insight from telomerase and brain imaging interaction. Transl. Psychiatry 3, e260 (2013).
    1. McClernon FJ, Kozink RV & Rose JE Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology 33, 2148–2157 (2008).
    1. Wetherill RR et al. The impact of sex on brain responses to smoking cues: a perfusion fMRI study. Biol. Sex Differ 4, 9 (2013).
    1. Joseph JE et al. Neural correlates of oxytocin and cue reactivity in cocaine-dependent men and women with and without childhood trauma. Psychopharmacology (Berl.) 10.1007/s00213-019-05360-7 (2019).
    1. Potenza MN et al. Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am. J. Psychiatry 169, 406–414 (2012).
    1. Kober H. et al. Brain activity during cocaine craving and gambling urges: an fMRI study. Neuropsychopharmacology 41, 628–637 (2016).
    1. Dong G. et al. Gender-related differences in cue-elicited cravings in Internet gaming disorder: the effects of deprivation. J. Behav. Addict 7, 953–964 (2018).
    1. Dong G. et al. Gender-related differences in neural responses to gaming cues before and after gaming: implications for gender-specific vulnerabilities to Internet gaming disorder. Soc. Cogn. Affect. Neurosci. 13, 1203–1214 (2018).
    1. Dong G. et al. Gender-related functional connectivity and craving during gaming and immediate abstinence during a mandatory break: implications for development and progression of internet gaming disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 88, 1–10 (2019).
    1. Franklin TR et al. Menstrual cycle phase modulates responses to smoking cues in the putamen: preliminary evidence for a novel target. Drug Alcohol Depend 198, 100–104 (2019).
    1. van Duijvenbode N. et al. Problematic alcohol use and mild intellectual disability: standardization of pictorial stimuli for an alcohol cue reactivity task. Res. Dev. Disabil 33, 1095–1102 (2012).
    1. Cuzzocreo JL et al. Effect of handedness on fMRI activation in the medial temporal lobe during an auditory verbal memory task. Hum. Brain Mapp 30, 1271–1278 (2009).
    1. Moriguchi Y. et al. Specific brain activation in Japanese and Caucasian people to fearful faces. Neuroreport 16, 133–136 (2005).
    1. Greer TM, Vendemia JM & Stancil M. Neural correlates of race-related social evaluations for African Americans and white Americans. Neuropsychology 26, 704–712 (2012).
    1. Volkow ND et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci 26, 6583–6588 (2006).
    1. Kosten TR et al. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31, 644–650 (2006).
    1. Prisciandaro JJ et al. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend 131, 44–49 (2013).
    1. Chase HW et al. The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biol. Psychiatry 70, 785–793 (2011).
    1. Wertz JM & Sayette MA Effects of smoking opportunity on attentional bias in smokers. Psychol. Addict. Behav 15, 268–271 (2001).
    1. Wilson SJ et al. Carry-over effects of smoking cue exposure on working memory performance. Nicotine Tob. Res. 9, 613–619 (2007).
    1. Engelmann JM et al. Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies. Neuroimage 60, 252–262 (2012).
    1. Moeller SJ et al. Neural correlates of drug-biased choice in currently using and abstinent individuals with cocaine use disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 3, 485–494 (2018).
    1. Coffey SF et al. Craving and physiological reactivity to trauma and alcohol cues in posttraumatic stress disorder and alcohol dependence. Exp. Clin. Psychopharmacol 18, 340–349 (2010).
    1. Potvin S. et al. Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. Schizophr. Res 173, 30–36 (2016).
    1. Wiers CE et al. Effects of depressive symptoms and peripheral DAT methylation on neural reactivity to alcohol cues in alcoholism. Transl. Psychiatry 5, e648 (2015).
    1. Goudriaan AE et al. Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. Addict. Behav. 38, 1509–1517 (2013).
    1. McHugh RK et al. Cue-induced craving to paraphernalia and drug images in opioid dependence. Am. J. Addict. 25, 105–109 (2016).
    1. Clayton RB, Bailey RL & Liu J. Conditioned “cross fading”: the incentive motivational effects of mediated-polysubstance pairings on alcohol, marijuana, and junk food craving. J. Health Commun 24, 319–327 (2019).
    1. Bach P. et al. The effects of single nucleotide polymorphisms in glutamatergic neurotransmission genes on neural response to alcohol cues and craving. Addict. Biol 20, 1022–1032 (2015).
    1. Blaine S. et al. TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin. Exp. Res 37, E125–E130 (2013).
    1. Chen J. et al. CREB-BDNF pathway influences alcohol cue-elicited activation in drinkers. Hum. Brain Mapp 36, 3007–3019 (2015).
    1. Filbey FM et al. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin. Exp. Res 32, 1113–1123 (2008).
    1. Janes AC et al. Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend 120, 7–13 (2012).
    1. Jorde A. et al. Genetic variation in the atrial natriuretic peptide transcription factor GATA4 modulates amygdala responsiveness in alcohol dependence. Biol. Psychiatry 75, 790–797 (2014).
    1. Kareken DA et al. A polymorphism in GABRA2 is associated with the medial frontal response to alcohol cues in an fMRI study. Alcohol Clin. Exp. Res 34, 2169–2178 (2010).
    1. Kuhn AB et al. FTO gene variant modulates the neural correlates of visual food perception. Neuroimage 128, 21–31 (2016).
    1. McClernon FJ et al. DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology (Berl.) 194, 433–441 (2007).
    1. Moeller SJ et al. Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence. J. Neurosci 33, 10027–10036 (2013).
    1. Schacht JP et al. Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status. Neuropsychopharmacology 42, 2640–2653 (2017).
    1. Schacht JP et al. Dopaminergic genetic variation influences aripiprazole effects on alcohol self-administration and the neural response to alcohol cues in a randomized trial. Neuropsychopharmacology 43, 1247–1256 (2018).
    1. Xu K. et al. A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk. Transl. Psychiatry 3, e292 (2013).
    1. Yang BZ et al. A preliminary study of DBH (encoding dopamine beta-hydroxylase) genetic variation and neural correlates of emotional and motivational processing in individuals with and without pathological gambling. J. Behav. Addict 5, 282–292 (2016).
    1. Poldrack RA et al. Guidelines for reporting an fMRI study. Neuroimage 40, 409–414 (2008).
    1. Albrecht J. et al. Potential impact of a 32-channel receiving head coil technology on the results of a functional MRI paradigm. Clin. Neuroradiol 20, 223–229 (2010).
    1. Panman JL et al. Bias introduced by multiple head coils in MRI research: an 8 channel and 32 channel coil comparison. Front. Neurosci 13, 729 (2019).
    1. Colizoli O. et al. Comparing fMRI responses measured at 3 versus 7 Tesla across human cortex, striatum, and brainstem. Preprint at 10.1101/2020.05.12.090175v1 (2020).
    1. Sacchet MD & Knutson B. Spatial smoothing systematically biases the localization of reward-related brain activity. Neuroimage 66, 270–277 (2013).
    1. Mayer AR et al. A comparison of denoising pipelines in high temporal resolution task-based functional magnetic resonance imaging data. Hum. Brain Mapp 40, 3843–3859 (2019).
    1. Poldrack RA et al. Scanning the horizon: towards transparent and reproducible neuroimaging research. Nat. Rev. Neurosci 18, 115–126 (2017).
    1. Lorenz RC et al. Cue reactivity and its inhibition in pathological computer game players. Addict. Biol 18, 134–146 (2013).
    1. Dale AM Optimal experimental design for event-related fMRI. Hum. Brain Mapp 8, 109–114 (1999).
    1. Josephs O. & Henson RN Event-related functional magnetic resonance imaging: modelling, inference and optimization. Philos. Trans. R Soc. Lond. B Biol. Sci 354, 1215–1228 (1999).
    1. Holla B. et al. Brain functional magnetic resonance imaging cue-reactivity can predict baclofen response in alcohol use disorders. Clin. Psychopharmacol. Neurosci 16, 290–301 (2018).
    1. Vollstädt-Klein S. et al. Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction 105, 1741–1749 (2010).
    1. Li X. et al. The neural mechanisms of immediate and follow-up of the treatment effect of hypnosis on smoking craving. Brain Imaging Behav 14, 1487–1497 (2020).
    1. Gusnard DA, Raichle ME & Raichle ME Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci 2, 685–694 (2001).
    1. Janes AC et al. Quitting starts in the brain: a randomized controlled trial of app-based mindfulness shows decreases in neural responses to smoking cues that predict reductions in smoking. Neuropsychopharmacology 44, 1631–1638 (2019).
    1. Dean AC et al. No effect of attentional bias modification training in methamphetamine users receiving residential treatment. Psychopharmacology 236, 709–721 (2019).
    1. Kang O-S et al. Individual differences in smoking-related cue reactivity in smokers: an eye-tracking and fMRI study. Prog. Neuropsychopharmacol. Biol. Psychiatry 38, 285–293 (2012).
    1. Hanlon CA et al. Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl. Psychiatry 8, 186 (2018).
    1. Mondino M. et al. Effects of repeated transcranial direct current stimulation on smoking, craving and brain reactivity to smoking cues. Sci. Rep 8, 8724 (2018).
    1. Yalachkov Y. et al. Sensory modality of smoking cues modulates neural cue reactivity. Psychopharmacology (Berl.) 225, 461–471 (2013).
    1. Manoliu A. et al. SmoCuDa: a validated smoking cue database to reliably induce craving in tobacco use disorder. Eur. Addict. Res 27, 107–114 (2021).
    1. Macatee RJ et al. Development and validation of a cannabis cue stimulus set. Addict. Behav 112, 106643 (2021).
    1. Stritzke WG et al. Assessment of substance cue reactivity: advances in reliability, specificity, and validity. Psychol. Addict. Behav 18, 148–159 (2004).
    1. Zeng H. et al. The action representation elicited by different types of drug-related cues in heroin-abstinent individuals. Front. Behav. Neurosci 12, 123 (2018).
    1. Lindsey KP et al. Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking. Pharmacol. Biochem. Behav 103, 710–716 (2013).
    1. Schacht JP, Anton RF & Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict. Biol 18, 121–133 (2013).
    1. Wall MB et al. Investigating the neural correlates of smoking: feasibility and results of combining electronic cigarettes with fMRI. Sci. Rep 7, 1–8 (2017).
    1. Ekhtiari H. et al. It is never as good the second time around: brain areas involved in salience processing habituate during repeated drug cue exposure in treatment engaged abstinent methamphetamine and opioid users. Neuroimage 238, 118180 (2021).
    1. Seo D. et al. Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry 70, 727–739 (2013).
    1. Chua HF et al. Self-related neural response to tailored smoking-cessation messages predicts quitting. Nat. Neurosci 14, 426–427 (2011).
    1. McClernon FJ et al. Hippocampal and insular response to smoking-related environments: neuroimaging evidence for drugcontext effects in nicotine dependence. Neuropsychopharmacology 41, 877–885 (2016).
    1. McClernon FJ et al. Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacology 30, 1940–1947 (2005).
    1. Li Q. et al. Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study. Brain Res 1469, 63–72 (2012).
    1. Kleykamp BA et al. Craving and opioid use disorder: a scoping review. Drug Alcohol Depend 205, 107639 (2019).
    1. Ekhtiari H. Craving as an Outcome Measure in Clinical Trials: A Systematic Review on Craving Assessment Instruments in Clinical Trials for Substance Use Disorders. Accessed 25 Aug 2021. (2021).
    1. Heishman SJ et al. Prolonged duration of craving, mood, and autonomic responses elicited by cues and imagery in smokers: effects of tobacco deprivation and sex. Exp. Clin. Psychopharmacol. 18, 245 (2010).
    1. Heishman SJ, Saha S. & Singleton EG Imagery-induced tobacco craving: duration and lack of assessment reactivity bias. Psychol. Addict. Behav 18, 284–288 (2004).
    1. Franken IH, Hendriks VM & Van den Brink W. Initial validation of two opiate craving questionnaires: The Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict. Behav 27, 675–685 (2002).
    1. Heishman SJ, Singleton EG & Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction 96, 1023–1034 (2001).
    1. Tiffany ST & Drobes DJ The development and initial validation of a questionnaire on smoking urges. Br. J. Addict. 86, 1467–1476 (1991).
    1. Kozlowski LT et al. “Cravings” are amibiguous: ask about urges or desires. Addict. Behav 14, 443–445 (1989).
    1. Kozlowski LT & Wilkinson DA Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br. J. Addict 82, 31–36 (1987).
    1. Wilson SJ & Sayette MA Neuroimaging craving: urge intensity matters. Addiction 110, 195–203 (2015).
    1. Plant RR, Hammond N. & Whitehouse T. How choice of mouse may affect response timing in psychological studies. Behav. Res. Methods Instrum. Comput 35, 276–284 (2003).
    1. Plant RR & Turner G. Millisecond precision psychological research in a world of commodity computers: new hardware, new problems? Behav. Res. Methods 41, 598–614 (2009).
    1. Segalowitz SJ & Graves RE Suitability of the IBM XT, AT, and PS/2 keyboard, mouse, and game port as response devices in reaction time paradigms. Behav. Res. Methods Instrum. Comput 22, 283–289 (1990).
    1. Schwarz AJ et al. A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #1: processes and requirements. Drug Discov. Today 16, 583–593 (2011).
    1. Sutton BP et al. Investigation and validation of intersite fMRI studies using the same imaging hardware. J. Magn. Reson. Imaging 28, 21–28 (2008).
    1. Carter BL & Tiffany ST Meta-analysis of cue-reactivity in addiction research. Addiction 94, 327–340 (1999).
    1. Chang C, Cunningham JP & Glover GH Influence of heart rate on the BOLD signal: the cardiac response function. Neuroimage 44, 857–869 (2009).
    1. Gloria R. et al. An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology 46, 681–693 (2009).
    1. Janes AC et al. Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence. Exp. Clin. Psychopharmacol 17, 365–373 (2009).
    1. Lou M. et al. Cue-elicited craving in heroin addicts at different abstinent time: an fMRI pilot study. Subst. Use Misuse 47, 631–639 (2012).
    1. McClernon FJ et al. 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum. Psychopharmacology (Berl.) 204, 25–35 (2009).
    1. Parvaz MA, Moeller SJ & Goldstein RZ Incubation of cue-induced craving in adults addicted to cocaine measured by electroencephalography. JAMA Psychiatry 73, 1127–1134 (2016).
    1. Lu L. et al. Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology 47, 214–226 (2004).
    1. Bailey SR, Goedeker KC & Tiffany ST The impact of cigarette deprivation and cigarette availability on cue-reactivity in smokers. Addiction 105, 364–372 (2010).
    1. Fischer H. et al. Brain habituation during repeated exposure to fearful and neutral faces: a functional MRI study. Brain Res. Bull 59, 387–392 (2003).
    1. Siegle GJ et al. Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51, 693–707 (2002).
    1. Franklin T. et al. Effects of varenicline on smoking cue-triggered neural and craving responses. Arch. Gen. Psychiatry 68, 516–526 (2011).
    1. LaRowe SD et al. Reactivity to nicotine cues over repeated cue reactivity sessions. Addict. Behav 32, 2888–2899 (2007).
    1. Schacht JP et al. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage 56, 61–68 (2011).
    1. McBride D. et al. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology 31, 2728–2738 (2006).
    1. Perry RN et al. The impacts of actual and perceived nicotine administration on insula functional connectivity with the anterior cingulate cortex and nucleus accumbens. J. Psychopharmacol 33, 1600–1609 (2019).
    1. Gu X. et al. Belief about nicotine modulates subjective craving and insula activity in deprived smokers. Front. Psychiatry 7, 126 (2016).

Source: PubMed

3
S'abonner